{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:19:34Z","timestamp":1779272374927,"version":"3.51.4"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2142,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1478-3231.2010.02257.x","type":"journal-article","created":{"date-parts":[[2010,5,14]],"date-time":"2010-05-14T15:00:33Z","timestamp":1273849233000},"page":"871-877","source":"Crossref","is-referenced-by-count":20,"title":["Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis"],"prefix":"10.1111","volume":"30","author":[{"given":"Aldo J.","family":"Montano-Loza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Wasilenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Bintner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,20]]},"reference":[{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB3|cit3","first-page":"1252","article-title":"Recurrent primary biliary cirrhosis","volume":"11","author":"Guy","year":"2005","journal-title":"peritransplant factors and ursodeoxycholic acid treatment post-liver transplant"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/jlts.2003.50132","article-title":"The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation","volume":"9","author":"Levitsky","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine a protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB9|cit9","first-page":"1578","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation","volume":"6","author":"McAlister","year":"2006","journal-title":"a meta-analysis"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB10|cit10","first-page":"837","article-title":"New insights from recurrent primary biliary cirrhosis in liver transplantation","volume":"45","author":"Wasilenko","year":"2007","journal-title":"the paradox of BEComing a fibroblast?"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB12|cit12","first-page":"737","article-title":"The causes of primary biliary cirrhosis","volume":"47","author":"Gershwin","year":"2008","journal-title":"convenient and inconvenient truths"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1053\/j.gastro.2004.10.024","article-title":"Patients with primary biliary cirrhosis make anti-viral and anti-mitochondrial antibodies to mouse mammary tumor virus","volume":"127","author":"Mason","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB14|cit14","first-page":"779","article-title":"Primary biliary cirrhosis, bacteria and molecular mimicry","volume":"29","author":"Wasilenko","year":"2009","journal-title":"what's the molecule and where's the mimic?"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1073\/pnas.1433063100","article-title":"Does a betaretrovirus infection trigger primary biliary cirrhosis?","volume":"100","author":"Xu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510240517","article-title":"Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis","volume":"24","author":"Van de Water","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/lt.20532","article-title":"Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation","volume":"12","author":"Firpi","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2003.11.080","article-title":"Specific inhibition of hepatitis C virus replication by cyclosporin A","volume":"313","author":"Nakagawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.molcel.2005.05.014","article-title":"Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase","volume":"19","author":"Watashi","year":"2005","journal-title":"Mol Cell"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/372359a0","article-title":"Specific incorporation of cyclophilin A into HIV-1 virions","volume":"372","author":"Franke","year":"1994","journal-title":"Nature"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/viro.1996.0421","article-title":"Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction","volume":"222","author":"Franke","year":"1996","journal-title":"Virology"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.177.1.443","article-title":"Novel activities of cyclophilin A and cyclosporin A during HIV-1 infection of primary lymphocytes and macrophages","volume":"177","author":"Saini","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hep.20024","article-title":"Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis","volume":"39","author":"Xu","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB24|cit24","first-page":"1579","article-title":"Changes in retrovirus expression in mouse mammary tumor cells in culture","volume":"41","author":"Arya","year":"1981","journal-title":"Cancer Res"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/AAC.00310-06","article-title":"NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon","volume":"50","author":"Ma","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/jac\/dkl136","article-title":"Lopinavir\/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration","volume":"57","author":"Rosso","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2036.2007.03402.x","article-title":"Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders","volume":"26","author":"McDermid","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/radiol.2273011499","article-title":"Correlation and simple linear regression","volume":"227","author":"Zou","year":"2003","journal-title":"Radiology"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2146\/ajhp070006","article-title":"Overview of biostatistics used in clinical research","volume":"66","author":"De Muth","year":"2009","journal-title":"Am J Health Syst Pharm"},{"issue":"(S","key":"10.1111\/j.1478-3231.2010.02257.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"P55","DOI":"10.1186\/1742-4690-6-S2-P55","article-title":"Isolation of a human betaretrovirus resembling mouse mammary tumor virus (MMTV) from patients with primary biliary cirrhosis (abstract)","volume":"6","author":"Indik","year":"2009","journal-title":"Retrovirology"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"e1000546","DOI":"10.1371\/journal.ppat.1000546","article-title":"Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics","volume":"5","author":"Kaul","year":"2009","journal-title":"PLoS Patho"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1128\/AAC.00498-08","article-title":"Combinations of cyclophilin inhibitor NIM811 with hepatitis C Virus NS3-4A Protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance","volume":"52","author":"Mathy","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2008.10.026","article-title":"Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis","volume":"50","author":"Johal","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2010.02257.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2004.05.033","article-title":"Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2010.02257.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2010.02257.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T12:53:21Z","timestamp":1625662401000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2010.02257.x"}},"subtitle":["Cyclosporine A inhibits betaretrovirus replication in vitro"],"short-title":[],"issued":{"date-parts":[[2009,10,20]]},"references-count":34,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02257.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,20]]}}}